This is an old revision of the document!
Medical Publications
Medical doctors, both clinicians and researchers, document and share their research by publishing it in medical journals. Typically the papers undergo a process of editorial review and peer review prior to publication. The papers can cover a wide variety of topics and types of research including controlled clinical trials, observational studies, case reports, laboratory research results, clinical research, pilot studies, feasibility studies, cohort studies, case control studies, cross sectional studies, in silico experiments, correspondence, and editorials.
Covid-19 Publications Link Dump
EUA for PCR Tests Withdrawn
Early Treatment & Therapeutics
The NIH therapeutic treatment recommendations.
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence
Synergistic Anti-SARS-CoV-2 Activity of Repurposed Anti-Parasitic Drug Combinations
Covid Interventions - Questions & Failure
A collection of over 400 studies on the failure of Covid interventions.
Leveraging epidemiological principles to evaluate Sweden’s COVID-19 response
Calling for benefit–risk evaluations of COVID-19 control measures
Heart-Related Issues with the Vaccines
Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel
The Impact of Anti-Depressants
Vaccine Development & Approval
An Overview Of Vaccine Development, Approval, And Regulation, With Implications For COVID-19
Vaccinating Children
Covid-19 vaccines for children: hypothetical benefits to adults do not outweigh risks to children
Children are unlikely to be the main drivers of the COVID-19 pandemic - A systematic review
Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
Why are we vaccinating children against COVID-19?
Deaths in Children and Adolescents Associated With COVID-19 and MIS-C in the United States
Vaccine Passports
Vaccine Effectiveness
Covid-19 Vaccine Effectiveness in New York State
Unclassified
Post-lockdown SARS-CoV-2 nucleic acid screening in nearly ten million residents of Wuhan, China
What reinfections mean for COVID-19
SARS-CoV-2 variant prediction and antiviral drug design are enabled by RBD in vitro evolution